Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
| Episode | Date |
|---|---|
|
Breaking News: Imvionix Acquires Beovu in the US and Canada
|
Nov 10, 2026 |
|
Business of Retina After the Midterms with Tom Stone, MD | Ehsan Rahimy, MD, on the PRIMA Implant
|
Nov 05, 2026 |
|
Big Pharma’s Retina Bets | Don D’Amico, MD, on BRUNELLO | RetinUp Turns One
|
Oct 29, 2026 |
|
Breaking News: Alcon Acquires Neurotech
|
Oct 21, 2026 |
|
Breaking News: LUCIA Misses in Wet AMD — EyePoint Shifts to DME
|
Oct 19, 2026 |
|
AAO 2026 Recap + Vitrectomy for Floaters with Christina Weng, MD, MBA
|
Oct 15, 2026 |
|
The 2026 Data Recap — What to Watch at AAO Next Week
|
Oct 01, 2026 |
|
Breaking News: Kodiak's DAYBREAK Hits — Zenkuda and Tabirafusp-ted Both Positive
|
Sep 28, 2026 |
|
Breaking News: Merck's Remigromig Hits Primary Endpoint in BRUNELLO for DME [Corrected]
|
Sep 25, 2026 |
|
Breaking News: Beacon's Gene Therapy Laru-zova Hits Primary Endpoint in VISTA for XLRP
|
Sep 23, 2026 |
|
AAO 2026 Preview | Retina Subspecialty Day & the Talks Worth Showing Up For
|
Sep 17, 2026 |
|
Pipeline Check-In | Plus Carl Danzig, MD, on His Mid-Career Practice Switch
|
Sep 03, 2026 |
|
Jay Duker, MD, on LUGANO and What Comes Next for Duravyu and EyePoint | Plus, Miles Harper on Successful and Failed OR Innovations
|
Aug 20, 2026 |
|
Breaking News: EyePoint's Phase 3 Topline Data Release
|
Aug 17, 2026 |
|
Oncology's Biosimilar Lessons for Retina | Plus, Moving to a New OR
|
Aug 13, 2026 |
|
Outlook CEO Bob Jahr on the Lytenava Launch | Plus, Miles Harper on Being Connective Tissue for Industry Innovation
|
Jul 30, 2026 |
|
Breaking News: FDA Approves Lytenava for Wet AMD
|
Jul 25, 2026 |
|
Devon Ghodasra, MD, on Biosimilars in Practice | Plus Vas Sadda, MD, on Ultra-Widefield Imaging for a Peripheral Detachment
|
Jul 23, 2026 |
|
Jorge Fortun, MD, on Patient Communication, Palm Beach Practice, & ASRS Preview
|
Jul 09, 2026 |
|
Hunter Cherwek, MD, on Orbis International | Plus Frank Brodie, MD, on LensOne & the GOLDEN GATE Trial
|
Jun 25, 2026 |
|
The Future of Bevacizumab | Plus John Miller, MD, on the Mass Eye and Ear Vitrectomy Course | Encelto for MacTel2
|
Jun 11, 2026 |
|
GLOBE Project & FDA Uncertainty | Arshad Khanani, MD, MA, on Clinical Trials at the Summit | Plus MacTel Image of the Month
|
May 28, 2026 |
|
ASP7317 for Geographic Atrophy | Plus, Moo Adam, MD, on IV-Free Surgery
|
May 14, 2026 |
|
Clorinda Walley, President & CEO of Good Days, on Patient Assistance Funding | Plus, Image of the Month with Prof. Paulo Stanga: Papillophlebitis on the Silverstone RGB
|
Apr 30, 2026 |
|
Darius Moshfeghi, MD, on the SOL-1 Study | Plus, Heads-Up 3D Visualization and Medicare Cut Concerns
|
Apr 16, 2026 |
|
2026 Vit Buckle Society Meeting Preview
|
Apr 02, 2026 |
|
Emergency Pod: Biogen to Acquire Apellis
|
Mar 31, 2026 |
|
Marion Munk on Photobiomodulation in AMD | Plus Oliver Hvidt on Norlase and Laser Technology
|
Mar 19, 2026 |
|
RetinUp Mailbag – Cash Pay Models, Emerging Therapies, and Tech Adoption During Reimbursement Reductions
|
Mar 05, 2026 |
|
Retina Wealth Strategy ft. David Mandell; ASRS Biz Recap + Maria Berrocal on Surgical Tech
|
Feb 19, 2026 |
|
Breaking News: SOL-1 Superiority Data for Axpaxli in Wet AMD
|
Feb 18, 2026 |
|
Dr. Thomas Albini on Angiogenesis '26: AI, GA Pipelines, Gene Therapy, and What Not to Miss
|
Feb 03, 2026 |
|
Elizabeth Cifers on Coding Risk, Modifier -25 Enforcement, and the Rise of Pre-Pay Audits
|
Jan 22, 2026 |
|
Leading Retina at Harvard, ft. Rishi P. Singh, MD; CMS GLOBE Model, EYLEA HD’s Expanded Label
|
Jan 08, 2026 |
|
Inside Cencora GPO: How GPOs Leverage Scale to Help Retina Practices Thrive, ft. Shane Dixon
|
Dec 18, 2025 |
|
How Cencora and Besse Medical Help Retina Specialists Thrive, ft. Eric Besse, VP at Besse Medical
|
Dec 04, 2025 |
|
Episode 3: Shutdown’s Effects on FDA ft. Alec Gaffney from POLITICO | Plus, PRIMA Implant + GLP-1 Data Dump
|
Nov 11, 2025 |
|
Episode 2: AAO Recap
|
Nov 06, 2025 |
|
Welcome to RetinUp: AAO recap and interview with Cedric Francois
|
Oct 30, 2025 |
|
Welcome to RetinUp
|
Oct 28, 2025 |